Management of systemic sclerosis-associated interstitial lung disease in the current era
Int J Rheum Dis
.
2020 Feb;23(2):137-139.
doi: 10.1111/1756-185X.13799.
Authors
Sogol Sara Amjadi
1
,
David Roofeh
2
,
Rajaie Namas
3
,
Dinesh Khanna
2
Affiliations
1
Dignity Health, Henderson, NV, USA.
2
Scleroderma Program, University of Michigan, Ann Arbor, MI, USA.
3
Division of Rheumatology, Cleveland Clinic, Ab Dhabi, United Arab Emirates.
PMID:
32043307
PMCID:
PMC7083212
DOI:
10.1111/1756-185X.13799
No abstract available
Publication types
Editorial
MeSH terms
Disease Management*
Female
Humans
Lung Diseases, Interstitial / etiology
Lung Diseases, Interstitial / therapy*
Male
Scleroderma, Systemic / complications*
Grants and funding
K24 AR063120/AR/NIAMS NIH HHS/United States
R01 AR-07047/NIH/NIAMS/International